Teicher BA - Search Results

1

Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease.

Teicher BA, Sotomayor EA, Huang ZD. Teicher BA, et al. Cancer Res. 1992 Dec 1;52(23):6702-4. Cancer Res. 1992. PMID: 1384969

2

Effect of a bovine hemoglobin preparation (SBHS) on the response of two murine solid tumors to radiation therapy or chemotherapeutic alkylating agents.

Teicher BA, Holden SA, Ara G, Herman TS, Hopkins RE, Menon K. Teicher BA, et al. Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):657-60. doi: 10.3109/10731199209119697. Biomater Artif Cells Immobilization Biotechnol. 1992. PMID: 1391491

3

Enhancement of fractionated radiation therapy by an experimental concentrated perflubron emulsion (Oxygent) in the Lewis lung carcinoma.

Teicher BA, Herman TS, Menon K. Teicher BA, et al. Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):899-902. doi: 10.3109/10731199209119737. Biomater Artif Cells Immobilization Biotechnol. 1992. PMID: 1391530

4

Whole-body hyperthermia as an adjuvant to treatment with platinum complexes with or without etanidazole in mice bearing the Lewis lung carcinoma or the FSaLL fibrosarcoma.

Teicher BA, Herman TS, Menon K, Korbut TT. Teicher BA, et al. Int J Hyperthermia. 1992 Nov-Dec;8(6):783-94. doi: 10.3109/02656739209005026. Int J Hyperthermia. 1992. PMID: 1479204 Free article.

5

Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.

Sotomayor EA, Teicher BA, Schwartz GN, Holden SA, Menon K, Herman TS, Frei E 3rd. Sotomayor EA, et al. Among authors: teicher ba. Cancer Chemother Pharmacol. 1992;30(5):377-84. doi: 10.1007/BF00689966. Cancer Chemother Pharmacol. 1992. PMID: 1505076

6

Interaction of D,L- and D-tetraplatin with hyperthermia in vitro and in vivo.

Epelbaum R, Teicher BA, Holden SA, Ara G, Varshney A, Herman TS. Epelbaum R, et al. Among authors: teicher ba. Eur J Cancer. 1992;28A(4-5):794-800. doi: 10.1016/0959-8049(92)90117-k. Eur J Cancer. 1992. PMID: 1524897

7

Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.

Holden SA, Teicher BA, Ara G, Herman TS, Coleman CN. Holden SA, et al. Among authors: teicher ba. J Natl Cancer Inst. 1992 Feb 5;84(3):187-93. doi: 10.1093/jnci/84.3.187. J Natl Cancer Inst. 1992. PMID: 1542129

8

A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.

Teicher BA, Holden SA, Ara G, Ha CS, Herman TS, Northey D. Teicher BA, et al. J Cancer Res Clin Oncol. 1992;118(7):509-14. doi: 10.1007/BF01225265. J Cancer Res Clin Oncol. 1992. PMID: 1624542

9

Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents.

Teicher BA, Herman TS, Hopkins RE, Menon K. Teicher BA, et al. J Cancer Res Clin Oncol. 1992;118(2):123-8. doi: 10.1007/BF01187500. J Cancer Res Clin Oncol. 1992. PMID: 1735732

10

Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo.

Teicher BA, Holden SA, Herman TS, Epelbaum R, Pardee AB, Dezube B. Teicher BA, et al. Anticancer Res. 1991 Jul-Aug;11(4):1555-60. Anticancer Res. 1991. PMID: 1746913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

425 results

Search Page

Filters